Efficacy and Safety of IBI351 in Combination with Sintilimab ± Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects with KRAS G12C Mutation [58]. This evidence concerns the gene KRAS and non-small cell squamous lung carcinoma.